Laurus Labs Limited vs TAKE Limited

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and TAKE Limited (TAKE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LAURUSLABS vs TAKE on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
16.24
19.74
P/B ratio
8.07
0.10%
Dividend yield
0.00%
₹16.47
EPS
₹0.74

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
35.00%
17.58%
Return on capital
15.37%
26.09%
EBITDA margin
-3.53%
13.07%
Net margin
20.02%

Growth

LAURUSLABS takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
-34.06%
3.91%
Profit CAGR (3Y) even
—

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹187 Cr
₹6,813 Cr
Revenue
₹54 Cr
₹890 Cr
Net profit
₹11 Cr
0.45
Debt / equity
0.00
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
TAKE Limited
  • + ["Company is almost debt free."]
  • − ["Stock is trading at 6.00 times its book value", "The company has delivered a poor sales growth of -41.2% over past five years."]
Laurus Labs Limited full analysis TAKE Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.